Recent Presentations

StemoniX / Molecular Devices Webinar

Due to the structural and functional complexity of the Central Nervous System (CNS), the ability to obtain accurate and predictive in-vitro models for drug discovery and toxicology screening has been lacking. To fill this gap, StemoniX has developed the microBrain 3D platform: pre-plated neural spheroids composed of human iPSC-derived cortical neurons and astrocytes of uniform composition and size.

 

This presentation details how the Molecular Devices FLIPR Penta and ImageXpress Micro Confocal systems have been used to functionally and structurally characterize microBrain 3D spheroids from both healthy and disease sources.

 

Key highlights:

  • Use of microBrain neuronal microspheroids

  • Calcium oscillations in neural spheroids

  • 3D image analysis of compound treated neural spheroids

  • Multi-parametric evaluation of neurotoxicity effects

BIO2020 Digital Panel Discussion

StemoniX CEO, Ping Yeh, participated in a panel on 

Organs on a Chip and AI: Realizing Potential Efficiencies in Drug Discovery. 

 

This panel explored how highly scalable iPSC-based technologies could deliver significant cost and time savings to the pharmaceutical industry, reduce animal testing, and potentially lead to safer, more effective human clinical trials.

Virtual Poster Session

ISSCR 2020

The StemoniX microBrain 3D platform was featured in a poster by our partners at
Molecular Devices:

Multiplexed automated assays for neurotoxicity evaluations using induced pluripotent stem cell-derived neural 3D cell models

SoT2020

Simultaneous Assessment of Oncology Compound Efficacy and Toxicity in a Neuronal Human Induced Pluripotent Stem Cell and Glioblastoma-Based High-Throughput Screening Platform

SoT2020

High-Throughput Anisotropic Human iPSC-Derived Cardiomyocyte Cultures Display Differential Response to Chronic Oncology Compound-Related Toxicity

SLAS2020

A Novel Objective Waveform Analysis for Providing Bias-free Multiparametric Outputs for Classifying Biological Mechanisms and High-Throughput Screening Results

SLAS2020

Assessment of compound efficacy and safety for glioblastoma treatment in a multiplexed human High Throughput Screening platform

SLAS2020

A human pancreatic spheroid platform for high throughput screening in toxicology and diabetes

SLAS2020

High Throughput profiling of cardio-active compound response between 2D monolayers, anisotropic and 3-dimensional human induced pluripotent stem cell-derived cardiomyocytes

13300 67th Ave N,

Maple Grove, MN 55311, United States

(855) 783-6669

©2020 by StemoniX. All Rights Reserved.

StemoniX, microOrgan, microHeart, microBrain, microPancreas are registered trademarks of StemoniX, Inc.

  • LinkedIn
  • Twitter